Can A New Cholesterol Drug Restore Merck’s Prominence In Heart Drugs?

Can A New Cholesterol Drug Restore Merck’s Prominence In Heart Drugs?

Source: 
Forbes
snippet: 

But, if successful, this drug has the potential to indeed become the PCSK9 inhibitor for the masses. It could bring Merck full circle back to the days of Mevacor and Zocor.